Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kajaste-Rudnitski

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Virology|February 25, 2011
TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elementsAnna Kajaste-Rudnitski, Sara S Marelli, Cinzia Pultrone, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 24, 2025
Chimeric enzymes enhance treatment potential for globoid cell leukodystrophy through hematopoietic stem cell gene therapyFederica Cascino, Alessandra Ricca, Ilaria Picciotti, et al.
Nature Communications|December 14, 2020
D-mannose suppresses macrophage IL-1β productionSimone Torretta, Alessandra Scagliola, Luisa Ricci, et al.
Cell Stem Cell|May 5, 2023
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapySamuele Ferrari, Erika Valeri, Anastasia Conti, et al.
AIDS (London, England)|April 25, 2013
M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replicationLuca Cassetta, Anna Kajaste-Rudnitski, Tiziana Coradin, et al.
Frontiers in Immunology|April 8, 2021
Corrigendum: Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene TransferMichela Comi, Giada Amodio, Laura Passeri, et al.
Frontiers in Immunology|July 23, 2020
Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene TransferMichela Comi, Giada Amodio, Laura Passeri, et al.
Human Gene Therapy|May 1, 2019
Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant <i>Ex Vivo</i> Gene Therapy SettingsCarolina Petrillo, Andrea Calabria, Francesco Piras, et al.
Science Translational Medicine|January 3, 2014
Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progressionGiulia Escobar, Davide Moi, Anna Ranghetti, et al.
Nature Biotechnology|July 1, 2020
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal trackingSamuele Ferrari, Aurelien Jacob, Stefano Beretta, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Virology|February 25, 2011
TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elementsAnna Kajaste-Rudnitski, Sara S Marelli, Cinzia Pultrone, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 24, 2025
Chimeric enzymes enhance treatment potential for globoid cell leukodystrophy through hematopoietic stem cell gene therapyFederica Cascino, Alessandra Ricca, Ilaria Picciotti, et al.
Nature Communications|December 14, 2020
D-mannose suppresses macrophage IL-1β productionSimone Torretta, Alessandra Scagliola, Luisa Ricci, et al.
Cell Stem Cell|May 5, 2023
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapySamuele Ferrari, Erika Valeri, Anastasia Conti, et al.
AIDS (London, England)|April 25, 2013
M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replicationLuca Cassetta, Anna Kajaste-Rudnitski, Tiziana Coradin, et al.
Frontiers in Immunology|April 8, 2021
Corrigendum: Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene TransferMichela Comi, Giada Amodio, Laura Passeri, et al.
Frontiers in Immunology|July 23, 2020
Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene TransferMichela Comi, Giada Amodio, Laura Passeri, et al.
Human Gene Therapy|May 1, 2019
Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant <i>Ex Vivo</i> Gene Therapy SettingsCarolina Petrillo, Andrea Calabria, Francesco Piras, et al.
Science Translational Medicine|January 3, 2014
Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progressionGiulia Escobar, Davide Moi, Anna Ranghetti, et al.
Nature Biotechnology|July 1, 2020
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal trackingSamuele Ferrari, Aurelien Jacob, Stefano Beretta, et al.
Pageof 5